| | | 20,000+ Fresh Resumes Monthly | |
|
|
| |
Click here or scroll down to respond to this candidateYour COVID-19 test resultNEGATIVEA negative result for this test means that SARS-CoV-2 RNA (the cause of COVID-Street Address ) was not detected in the collected sample. What does it mean to have a negative test result?A negative test result does not completely rule out being infected with COVID-Street Address . If you test negative for COVID-19, this means the virus was not detected at the time your specimen was collected. It is still possible that you were very early in your infection at the time of your specimen collection and that you could test positive later. Also, you could be exposed later and still develop the illness. For all these reasons, it is important to follow CDC guidance, including but not limited to frequent hand washing, social distancing, wearing a face covering, covering coughs and sneezes, monitoring symptoms, and cleaning and disinfectant of frequently touched surfaces - even after a negative test result. Test informationPatient&#Street Address ;s name Collection datePeter Cheeks August 2, Street Address at 11:40 AM CDTCandidate's Name of birth Collection locationNovember 12, 1975 3802 BROAD STREET, MANSFIELD, TX 76063Test typeSARS-COV-2 RNA, QL, RT PCR (COVID-19)ProviderMATHEW RACHELMinuteClinic contact informationCustomer Service: PHONE NUMBER AVAILABLEInfo about this testA Not Detected result means that SARS-CoV-2 RNA was not present in the specimen above the limit of detection. A Not Detected result does not rule out the possibility of COVID-19 and should not be used as the sole basis for treatment or patient management decisions. If COVID-19 is still suspected, based on exposure history together with other clinical findings, re-testing should be considered in the context of clinical observations and epidemiological data for patient management decisions.Test Method: Nucleic Acid Amplification Test including reverse transcription polymerase chain reaction (RT-PCR) and transcription mediated amplification (TMA). The test method meets the US Centers for Disease Control and prevention (CDC) pre departure and arrival requirement for viral test for COVID-19 dated January 28, 2021. Testing requirements for traveling may change with time. The patient is responsible for determining the test requirements for each nation while they are traveling.This test has been authorized by the FDA under an Emergency Use Authorization (EUA) for use by authorized laboratories.Please review the "Fact Sheets" and FDA authorized labeling available for health care providers and patients using the following websites:https://www.questdiagnostics.com/home/Covid-19/HCP/NAAT/fact-sheet2 https://www.questdiagnostics.com/home/Covid-19/Patients/NAAT/fact-sheet2 Due to the current public health emergency, Quest Diagnostics is accepting samples from appropriate clinical sources collected using wide variety of swabs and transport media for COVID-19. Not detected test results derived from specimens received in non- commercially manufactured viral collection kits or those not yet authorized by FDA for COVID-19 testing should be cautiously evaluated and take extra precautions such as additional clinical monitoring, including collection of an additional specimen. Additional information about COVID-19 can be found at the Quest Diagnostics website: www.QuestDiagnostics.com/ Covid19.For patients with a Detected or Inconclusive test result, please see CDC's COVID-19 Treatments and Medications page located athttps://www.cdc.gov/coronavirus/2019-ncov/your-health/treatments-for-severe-illness.html for information on COVID-19 therapeutics.For patients with a Not Detected test result, please see CDC's Vaccines for COVID-19 page located at https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.htmlfor information on COVID-19 vaccines. |
